MyFinsight
Home
About
Contact
mirm: the income statement
Download
Download image
Bile Acid Medicines
$40,775K
Livmarli
$92,235K
Product
$133,010K
Total revenue
$133,010K
(47.17%↑ Y/Y)
Other income
(expense), net
$395K
(136.34%↑ Y/Y)
Interest income
$3,251K
(-6.28%↓ Y/Y)
Income (loss) from
operations
$2,603K
(120.52%↑ Y/Y)
Total operating
expenses
$130,407K
(26.53%↑ Y/Y)
(benefit from) provision
for income taxes
-$262K
(-175.50%↓ Y/Y)
Net income (loss)
before provision for...
$2,643K
(119.03%↑ Y/Y)
Interest expense
$3,606K
(0.56%↑ Y/Y)
Selling, general and
administrative
$61,910K
(22.48%↑ Y/Y)
Research and development
$42,960K
(35.48%↑ Y/Y)
Cost of sales
$25,537K
(22.74%↑ Y/Y)
Net income (loss)
$2,905K
(120.41%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)